An Explorative Trial Evaluating the Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)
Latest Information Update: 27 Nov 2015
At a glance
- Drugs LEO 39652 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors LEO Pharma
- 01 Feb 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 21 Aug 2014 New trial record